Chemours (CC) | Financial Analysis & Statements
Chemours Co. Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.3B
Gross Profit
156.0M
11.73%
Operating Income
-5.0M
-0.38%
Net Income
-62.0M
-4.66%
Balance Sheet Metrics
Total Assets
7.4B
Total Liabilities
7.1B
Shareholders Equity
251.0M
Debt to Equity
28.41
Cash Flow Metrics
Operating Cash Flow
117.0M
Free Cash Flow
92.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Chemours Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.8B | 5.8B | 6.0B | 6.8B | 6.3B |
| Cost of Goods Sold | 4.9B | 4.6B | 4.7B | 5.2B | 5.0B |
| Gross Profit | 902.0M | 1.2B | 1.3B | 1.6B | 1.4B |
| Gross Margin % | 15.5% | 19.9% | 21.7% | 23.8% | 21.8% |
| Operating Expenses | |||||
| Research & Development | 108.0M | 109.0M | 108.0M | 118.0M | 107.0M |
| Selling, General & Administrative | 799.0M | 585.0M | 1.3B | 710.0M | 592.0M |
| Other Operating Expenses | 23.0M | 14.0M | 31.0M | 2.0M | 8.0M |
| Total Operating Expenses | 930.0M | 708.0M | 1.4B | 830.0M | 707.0M |
| Operating Income | -28.0M | 443.0M | -123.0M | 786.0M | 674.0M |
| Operating Margin % | -0.5% | 7.7% | -2.0% | 11.6% | 10.6% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 269.0M | 264.0M | 208.0M | 163.0M | 185.0M |
| Other Non-Operating Income | 20.0M | -52.0M | 13.0M | 118.0M | 187.0M |
| Pre-tax Income | -277.0M | 127.0M | -318.0M | 741.0M | 676.0M |
| Income Tax | 109.0M | 41.0M | -81.0M | 163.0M | 68.0M |
| Effective Tax Rate % | 0.0% | 32.3% | 0.0% | 22.0% | 10.1% |
| Net Income | -386.0M | 86.0M | -237.0M | 578.0M | 608.0M |
| Net Margin % | -6.6% | 1.5% | -3.9% | 8.5% | 9.6% |
| Key Metrics | |||||
| EBITDA | 376.0M | 801.0M | 248.0M | 1.2B | 1.1B |
| EPS (Basic) | $-2.57 | $0.58 | $-1.60 | $3.72 | $3.69 |
| EPS (Diluted) | $-2.57 | $0.57 | $-1.60 | $3.65 | $3.60 |
| Basic Shares Outstanding | 150237101 | 149494462 | 148912397 | 150046614 | 164943575 |
| Diluted Shares Outstanding | 150237101 | 149494462 | 148912397 | 150046614 | 164943575 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Chemours Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 670.0M | 713.0M | 1.2B | 1.1B | 1.5B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 562.0M | 619.0M | 509.0M | 509.0M | 644.0M |
| Inventory | 1.6B | 1.5B | 1.4B | 1.4B | 1.1B |
| Other Current Assets | 80.0M | 71.0M | 66.0M | 82.0M | 75.0M |
| Total Current Assets | 3.0B | 3.0B | 3.8B | 3.2B | 3.3B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 8.6B | 8.2B | 7.9B | 8.0B | 7.8B |
| Goodwill | 94.0M | 95.0M | 207.0M | 217.0M | 210.0M |
| Intangible Assets | 2.0M | 3.0M | 3.0M | 13.0M | 6.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 682.0M | 750.0M | 620.0M | 675.0M | 492.0M |
| Total Non-Current Assets | 4.4B | 4.5B | 4.4B | 4.4B | 4.2B |
| Total Assets | 7.4B | 7.5B | 8.3B | 7.6B | 7.6B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 929.0M | 1.1B | 1.1B | 1.2B | 1.1B |
| Short-term Debt | 104.0M | 107.0M | 106.0M | 92.0M | 84.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | 90.0M | 83.0M |
| Total Current Liabilities | 1.7B | 1.8B | 2.5B | 1.9B | 1.9B |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.3B | 4.2B | 4.2B | 3.8B | 3.9B |
| Deferred Tax Liabilities | 37.0M | 35.0M | 44.0M | 61.0M | 49.0M |
| Other Non-Current Liabilities | 122.0M | 114.0M | 113.0M | 109.0M | 63.0M |
| Total Non-Current Liabilities | 5.4B | 5.1B | 5.0B | 4.6B | 4.6B |
| Total Liabilities | 7.1B | 6.9B | 7.5B | 6.5B | 6.5B |
| Equity | |||||
| Common Stock | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M |
| Retained Earnings | 1.2B | 1.7B | 1.8B | 2.2B | 1.7B |
| Treasury Stock | 1.8B | 1.8B | 1.8B | 1.7B | 1.2B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 251.0M | 605.0M | 739.0M | 1.1B | 1.1B |
| Key Metrics | |||||
| Total Debt | 4.4B | 4.4B | 4.3B | 3.9B | 4.0B |
| Working Capital | 1.3B | 1.2B | 1.3B | 1.3B | 1.5B |
Balance Sheet Composition
Chemours Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -386.0M | 86.0M | -237.0M | 578.0M | 608.0M |
| Depreciation & Amortization | 340.0M | 301.0M | 307.0M | 291.0M | 317.0M |
| Stock-Based Compensation | 21.0M | 15.0M | 18.0M | 27.0M | 34.0M |
| Working Capital Changes | 178.0M | -1.1B | 620.0M | -103.0M | 21.0M |
| Operating Cash Flow | 276.0M | -692.0M | 645.0M | 796.0M | 913.0M |
| Investing Activities | |||||
| Capital Expenditures | -213.0M | -360.0M | -370.0M | -307.0M | -277.0M |
| Acquisitions | - | - | - | - | 0 |
| Investment Purchases | - | - | - | - | -12.0M |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -205.0M | -355.0M | -221.0M | -287.0M | 220.0M |
| Financing Activities | |||||
| Share Repurchases | 0 | 0 | -69.0M | -495.0M | -173.0M |
| Dividends Paid | -78.0M | -148.0M | -149.0M | -154.0M | -164.0M |
| Debt Issuance | 828.0M | 699.0M | 771.0M | 105.0M | 741.0M |
| Debt Repayment | -889.0M | -604.0M | -378.0M | -185.0M | -949.0M |
| Financing Cash Flow | -126.0M | -45.0M | 153.0M | -737.0M | -577.0M |
| Free Cash Flow | 51.0M | -993.0M | 186.0M | 448.0M | 537.0M |
| Net Change in Cash | -55.0M | -1.1B | 577.0M | -228.0M | 556.0M |
Cash Flow Trend
Chemours Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
67.83
Forward P/E
10.34
Price to Book
14.22
Price to Sales
0.61
PEG Ratio
10.34
Profitability Ratios
Profit Margin
-6.65%
Operating Margin
2.03%
Return on Equity
-93.80%
Return on Assets
2.49%
Financial Health
Current Ratio
1.78
Debt to Equity
1,750.60
Beta
1.40
Per Share Data
EPS (TTM)
$-2.57
Book Value per Share
$1.67
Revenue per Share
$38.66
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CC | 3.6B | 67.83 | 14.22 | -93.80% | -6.65% | 1,750.60 |
| Linde plc | 236.5B | 34.73 | 6.16 | 17.82% | 20.30% | 70.63 |
| Sherwin-Williams | 83.7B | 32.88 | 18.09 | 59.39% | 10.90% | 306.06 |
| Element Solutions | 9.3B | 48.25 | 3.46 | 7.51% | 7.48% | 64.06 |
| Eastman Chemical | 8.2B | 17.58 | 1.38 | 7.99% | 5.42% | 84.41 |
| Arcadium Lithium plc | 6.3B | 64.89 | 1.00 | 2.78% | 10.24% | 14.03 |
Financial data is updated regularly. All figures are in the company's reporting currency.






